HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Camptothecin

HCID 24360
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
7689-03-4
Standard SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1
InChIKey
VSJKWCGYPAHWDS-FQEVSTJZSA-N
Molecular formula
C20H16N2O4
Average molar mass
348.4 g/mol
Monoisotopic mass
348.111007

Overview

Camptothecin is a pyranoindolizinoquinoline that is pyrano[3',4':6,7]indolizino[1,2-b]quinoline which is substituted by oxo groups at positions 3 and 14, and by an ethyl group and a hydroxy group at position 4 (the S enantiomer). It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, a genotoxin and a plant metabolite. It is a delta-lactone, a quinoline alkaloid, a tertiary alcohol and a pyranoindolizinoquinoline.

Names & identifiers

Preferred name
Camptothecin
IUPAC
(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
English name
(+)-Camptothecin
Molecular formula
C20H16N2O4
Molecular weight
348.35

Names & synonyms

camptothecinCamptothecine7689-03-4(S)-(+)-Camptothecind-Camptothecin(+)-Camptothecin20(S)-Camptothecine(+)-Camptothecine21,22-Secocamptothecin-21-oic acid lactoneNSC94600NSC-94600DTXSID0030956
Show more names
CaMpathecin(20S)-CAMPTOTHECIN5,6-DIHYDROXY-7-GLUCURONOSYLFLAVONECAMPTOTHECIN, CAMPTOTHECA ACUMINATA1,6-DIHYDROXY-7-GLUCURONOSYLFLAVONECS-1388
XT3Z54Z28A(4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dioneCHEBI:276561H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-(4S)-4-ETHYL-4-HYDROXY-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-

Database identifiers

CAS
7689-03-4
PubChem CID
24360
DTXSID
DTXSID0030956
ChEMBL
CHEMBL65
ChEBI
CHEBI:27656
UNII
XT3Z54Z28A
EC Number
444-280-6、616-407-7
Nikkaji
J2.266G

Properties

Computed structural properties

XLogP
1
Topological polar surface area
79.7 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
1
Heavy atoms
26
Formal charge
0
Complexity
742

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Melting Point275-277 °C
Collision Cross Section · 2 items

178.86 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

181.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
260 °C · 260 °C (dec.)(lit.)
alpha
25 · D25 +31.3° (in chloroform-methanol, 8:2)
Boiling point
482.73 °C · 482.73°C (rough estimate)
Density
1.3112 · 1.3112 (rough estimate)
refractive index
1.57 · 1.5700 (estimate)
storage temp.
2 · 2-8°C
solubility
4 · chloroform/methanol (4:1): 4 mg/mL
form
solid
pka
10.83 · pKa 10.83 (Uncertain)
color
yellow
optical activity
Consistent with structure
Water Solubility
insoluble
Merck
14 · 14,1735
BRN
631069 · 631069
Stability
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
InChI
1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1
InChIKey
VSJKWCGYPAHWDS-FQEVSTJZSA-N
SMILES
CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5ccccc5nc34)C2=O
LogP
1.74 · 1.740
CAS DataBase Reference
7689 · 7689-03-4(CAS DataBase Reference)
NCI Dictionary of Cancer Terms
camptothecin
FDA UNII
3 Z54Z28A · XT3Z54Z28A
Comptox DTXSID
30956 · DTXSID0030956
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Symbol(GHS)
6 · GHS06,GHS08
Signal word
Danger
Hazard statements
301 · H301-H340
Precautionary statements
202 · P202-P264-P270-P280-P301+P310-P405
PPE
2 · Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Hazard Codes
T,Xi,Xn
Risk Statements
36 · 36/37/38-25-20/21/22
Safety Statements
45 · 45-36/37/39-26-36
RIDADR
1544 · UN 1544 6.1/PG 3
WGK Germany
3 · 3
RTECS
492000 · UQ0492000
Hazard Note
Irritant
HazardClass
6.1 · 6.1
PackingGroup
Ⅲ
HS Code
29399990 · 29399990
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralMuta · Acute Tox. 3 OralMuta. 1B
REACH Registrations
Inactive
Limited Quantities
5 kg · 5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Danger

H301 (98%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P264, P270, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 50 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301 (97.1%): Toxic if swallowed [Danger Acute toxicity, oral]

Hazard information

Regulatory InformationREACH registered substance: (S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (EC: 444-280-6)
Hazard Classes and Categories · 2 items

Acute Tox. 3 (98%)

Acute Tox. 3 (97.1%)

Safety data

PPE
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
wgk
3
rtecs
UQ0492000
ridadr
UN 1544 6.1/PG 3
hs_code
29399990
risk_code
36/37/38-25-20/21/22
Signal word
Danger
Symbol(GHS)
GHS06,GHS08
hazard_code
T,Xi,Xn
hazard_note
Irritant
safety_code
45-36/37/39-26-36
hazard_class
6.1
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
Ⅲ
Hazard statements
H301-H340
Limited Quantities
5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)
REACH Registrations
Inactive
Hazard Classifications
Acute Tox. 3 OralMuta. 1B
Precautionary statements
P202-P264-P270-P280-P301+P310-P405

Chemistry & industry

Pharmacology

Pharmacodynamics · 1 item

Camptothecin demonstrated strong anticancer activity in preliminary clinical trials but also low solubility and adverse drug reaction. Camptothecin is believed to be a potent topoisomerase inhibitor that interferes with the essential function of topoisomerase in DNA replication.

Mechanism of ActionCamptothecin binds to the topoisomerase I and DNA complex resulting in a ternary complex, stabilizing it and preventing DNA re-ligation and therefore causes DNA damage which results in apoptosis.
MeSH Pharmacological Classification · 2 items

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.

Compounds that inhibit the activity of DNA TOPOISOMERASE I.

Applications · 7 items

DescriptionCamptothecin is an alkaloid derived from Xi Shu (Camptotheca acuminata), which belongs to Nyssaceae. The traditional Chinese medicine Camptotheca acuminata (Xi Shu) has been collected in the Compilation of Chinese Herbal Medicine, Chinese Materia Medica, and Great Dictionary of Chinese Medicine. Camptotheca acuminata (Xi Shu) is widely distributed in the basin of Yangtze river and the southwestern provinces. The main medicinal parts of Camptotheca acuminata (Xi Shu) are root bark and fruit, which get rid of heat and toxic materials and eliminate the disease.

DescriptionDNA topoisomerases relax DNA torsional strain created during replication, transcription, recombination, repair, and chromosome condensation. The relaxation of DNA supercoiling by topoisomerase I at single-strand breaks enables anticancer agents to reversibly trap the complex by intercalating between DNA base pairs at the cleavage site, thus inhibiting religa Camptothecin is a cytotoxic, quinoline alkaloid, discovered as the active principle of extracts from the Chinese tree C. acuminate, that inhibits the DNA enzyme topoisomerase I (Top1). It binds the Top1-DNA cleavage complex, inducing DNA-strand breaks. Camptothecin has strong anti-tumor activity against a wide range of experimental tumors and inhibits both DNA and RNA synthesis in mammalian cells. It displays cytotoxity in HT-29 cells with an IC50 value of 10 nM and induces DNA damage at concentrations as low as 51 nM in whole cells and 12 nM in isolated nuclei in in vitro assays.

HistoryIn 1966, Wall M E et al. from the United States isolated an alkaloid from Camptotheca acuminata and defined its chemical structure. The invitro anticancer tests revealed the anticancer activity of the tryptophan-terpene alkaloid, which is known as camptothecin and received widely concern. In 1975, Corey etal. first opened the door for the chiral synthesis of camptothecin, but the reaction step was long and the yield rate was very low. It was not until 1997 that Ciufolini etal. developed a new method for the synthesis of camptothecin by five steps, with a total yield rate up to 51%. The great breakthrough in the chemical synthesis of camptothecin has made its extensive application become a reality.Hydroxycamptothecin, as a camptothecin derivative with a hydroxyl group on the tenth carbon atom, is widely used for the treatment of various cancers. In 1969, researchers from Shanghai Institute of Materia Medica found that hydroxycamptothecin possessed potent anticancer activity and low toxicity. And this finding promoted the production and clinical application of hydroxycamptothecin, but its usage was interrupted for technology and quality. In the 1980s, hydroxycamptothecin was reproduced for clinical application with an improvement in producing technology, and hydroxycamptothecin got its approval number in 1986 for clinical usage in China. In the 1990s, the US Food and Drug Administration approved the clinical application of topotecan and irinotecan, which played a significant role in the prevention and treatment of cancers.

UsesAntitumor alkaloid. Binds irreversible to the DNA-topoisomerase I complex, inhibiting the reassociation of DNA after cleavage by topoisomerase I and traps the enzyme in a covalent linkage with DNA. A cytotoxic antitumor agent

Usesantineoplastic

UsesAntitumor agent;Topoisomerase I inhibitor

Uses10-hydroxycamptothecine precursor, topoisomerase inhibitor, binds irreversibly to DNA-topoisomerase I complex

Upstream & downstream products

Upstream raw materials

Methanol solution

Downstream products

IrinotecanCamtobell hydrochlorideSODIUM CAMPTOTHECIN(S)-11-DiMethoxyMethyl-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a -diaza-dibenzo[b,h]fluorene-3,13-dioneTOPOTECANACETATE

Additional notes

DefinitionChEBI: A pyranoindolizinoquinoline that is pyrano[3',4':6,7]indolizino[1,2-b]quinoline which is substituted by oxo groups at positions 3 and 14, and by an ethyl group and a hydroxy group at position 4 (the S enantiomer).

Related reactions

62 records
New reaction record
HRID 255805 reaction equation
HRID 255805As reactant
HRID 255806 reaction equation
HRID 255806As reactant
HRID 255807 reaction equation
HRID 255807As reactant
HRID 255808 reaction equation
HRID 255808As reactant
HRID 255809 reaction equation
HRID 255809As reactant
HRID 255810 reaction equation
HRID 255810As reactant
HRID 255811 reaction equation
HRID 255811As reactant
HRID 260182 reaction equation
HRID 260182As product
PreviousPage 1 of 8

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes